Modern Practical Healthcare Issues in Biomedical Instrumentation, Volume , 1 January 2021
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reducing Inequalities by using the statement "The negative impact of disability should have minimal effect on a person’s quality of life" to motivate research of a wearable headpiece and electronic mechanical wheelchair unit.
The Lancet Psychiatry, Volume 8, January 2021
This article ties to SDG 3. In this study, time-varying associations of pre-migration and post-migration stressors in refugees' mental health were explored. Understanding these time-varying association could help in designing tailored health promotion services at different resettlement stages and improving the efficiency of resource allocation.
Free Radical Biology and Medicine, Volume 162, January 2021
Proteasome function is impaired in Alzheimer's disease (AD). Proteasome activation is followed by a decrease in amyloid-beta (Aβ) load. A reduced amount of Aβ correlates with significantly improved behavior and frailty level. Proteasome activation represents a promising intervention for alleviating AD pathology.
This is a special issue on food systems for children and adolescents with research on food marketing, nutrition and sustaining healthy diets and food supply chains. It brings together research advancing SDGs 2, zero hunger, SDG 3, good health and wellbeing and SDG 12, responsible production and consumption.
Low Carbon Energy Technologies in Sustainable Energy Systems, 2021, Pages 3-24
This chapter advances SDG 6, 7, and 11 by examining the role of resource recovery technologies in reducing the demand of fossil fuels and conventional fossil-based mineral fertilizers, including through the production of sustainable biofuels such as hydrogen, syngas, and bio-oil.
Redox Biology, Volume 38, January 2021
Imbalances in redox homeostasis can result in oxidative stress, which is implicated in various pathological conditions including the fatal neuromuscular disease Duchenne Muscular Dystrophy (DMD). DMD is a complicated disease, with many druggable targets at the cellular and molecular level including calcium-mediated muscle degeneration; mitochondrial dysfunction; oxidative stress; inflammation; insufficient muscle regeneration and dysregulated protein and organelle maintenance. Previous investigative therapeutics tended to isolate and focus on just one of these targets and, consequently, therapeutic activity has been limited. Nuclear erythroid 2-related factor 2 (Nrf2) is a transcription factor that upregulates many cytoprotective gene products in response to oxidants and other toxic stressors. Unlike other strategies, targeted Nrf2 activation has the potential to simultaneously modulate separate pathological features of DMD to amplify therapeutic benefits. Here, we review the literature providing theoretical context for targeting Nrf2 as a disease modifying treatment against DMD.
Journal of Integrative Agriculture, Volume 20, January 2021
Using China Health and Nutrition Survey data, this study employs a consistent two-step quadratic almost ideal demand system model, with addressed problems of endogeneity of total expenditure and zero shares, to estimate the food demand elasticities among adults in rural areas with regard to the different income strata.
Elsevier, Journal of Sexual Medicine, Volume 17, December 2020
Background: Sexual dysfunction and sexual distress are common during pregnancy, but the effects of exposure to sexual violence on sexual dysfunction and sexual distress in pregnant women is unknown. Aim: The aim of this study was to determine the effects of sexual violence on female sexual dysfunction and sexual distress. Methods: This is a descriptive study. Data were collected between December 2019 and April 2020 from 605 pregnant women.